MODIFICATION TO COPALIS CMV TOTAL ANTIBODY ASSAY

Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus

DIASORIN, INC.

The following data is part of a premarket notification filed by Diasorin, Inc. with the FDA for Modification To Copalis Cmv Total Antibody Assay.

Pre-market Notification Details

Device IDK982027
510k NumberK982027
Device Name:MODIFICATION TO COPALIS CMV TOTAL ANTIBODY ASSAY
ClassificationEnzyme Linked Immunoabsorbent Assay, Cytomegalovirus
Applicant DIASORIN, INC. 9175 GUIFORD RD. Columbia,  MD  21046
ContactJudith J Smith
CorrespondentJudith J Smith
DIASORIN, INC. 9175 GUIFORD RD. Columbia,  MD  21046
Product CodeLFZ  
CFR Regulation Number866.3175 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-06-02
Decision Date1998-11-25
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.